Clinical Trial

Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

Study acronym: GAINPCCONTROL
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 29, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
GAIN PC CONTROL is a study investigating Glucagon-Like Peptide-1 Receptor Agonists in men with prostate cancer who are being treated with androgen deprivation therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-02.
Status change: Not Yet Recruiting → Recruiting 2025-07-25
Trial Details
NCT Number NCT06908694
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: McMaster University
Conditions Prostate Cancer
Enrollment 20 participants
Start Date 2025-07-02
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-29